Clinical trials are central to advancing treatments for movement disorders. This track will highlight on-going and emerging clinical trials, with a focus on novel therapies, patient populations, and the future of clinical research in Parkinson’s, Huntington’s, and related diseases.
Track 24-1: Current Clinical Trials in Parkinson’s Disease
Track 24-2: New Approaches in Huntington’s Disease Trials
Track 24-3: Emerging Therapies in Dystonia and Tremor
Track 24-4: Gene Therapy Clinical Trials
Track 24-5: Evaluating Novel Interventions in Movement Disorders
This track will offer participants the latest updates on clinical research and emerging therapies, providing a glimpse into the future of movement disorder treatments.
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
